Being A Preferred Partner: Spero Therapeutics’ Plans For Growth

Erin Wenzel, director of alliance management at Spero Therapeutics, talks to In Vivo about working with a big pharma partner and Spero’s strategy for future growth.

Dealmaking concept
Being flexible and keeping the wheels turning in biopharma R&D • Source: Shutterstock

More from Rising Leaders

More from Leadership